AANEM News Express

AANEM News Express

Science News: ASC-1 is a Cell Cycle Regulator Associated With Severe and Mild Forms of Myopathy

10/14/2020
 
NSEB.jpgSubmitted by Clark Pinyan, MD

ASC-1 is a Cell Cycle Regulator Associated With Severe and Mild Forms of Myopathy
Villar-Quiles RN, et al. Ann Neurol 2020;87:217-232
 

Dysfunction of the transcriptional coactivator ASC-1 (activating signal cointegrator 1) complex has been demonstrated in forms of ALS, SMA, and congenital myopathies. Mutations in TRIP4 gene, which encodes ASC-1, has been described recently in a family with congenital myopathy. This study assesses 5 different families with 7 novel TRIP4 mutations. All mutations caused ASC-1 depletion. Clinical phenotype was purely myopathic, ranging from lethal neonatal to mild ambulatory adult. Muscle biopsies showed multiminicores, nemaline rods, cytoplasmic bodies, caps, central nuclei, rimmed fibers and / or mild endomysial fibrosis. ASC-1 depletion in CSC12 and patient-derived fibroblasts and muscles caused accelerated proliferation, altered expression of celll cycle proteins, and /or shortening of the G0/G1 cell cycle phase leading to cell size reduction.


Comments: There is increasing recognition that ASC complex and other transcriptional modulators are important in pathological processes whether acquired or inherited. Defining the range of disease associated with defects in this gene may lead to understanding the final common pathologic mechanisms and potential interventions.


View Related News Stories:

  EducationScience News NSEB


Recent AANEM News

Meet the AANEM's 2021 President

Science News: Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China

Science News: COVID-19 and Neuromuscular Disorders

ALS Patients Find Hope in New Study Authored by AANEM Members

More than 1,660 People Attend the AANEM 2020 Virtual Annual Meeting





Advertisement

ABEM

Advertisement

argenx gMG cycle

Advertisement